IPP Bureau
Nanyang Biologics, NVIDIA, HPE & Equinix to launch AI drug discovery platform
By IPP Bureau - September 16, 2025
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter secures seed investment to scale drug discovery knowledge platform
By IPP Bureau - September 16, 2025
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Senhwa Biosciences’ Pidnarulex joins forces with global PD-1 leaders to advance next-gen immunotherapy
By IPP Bureau - September 16, 2025
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Rona submits IND for GalNAc-conjugated siRNA targeting obesity
By IPP Bureau - September 16, 2025
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
Atom enrolls first patient in global phase 2 trial of ABP-745 for acute gout flares
By IPP Bureau - September 16, 2025
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Ascletis' ASC30 obesity drug shows 75-day half-life in US Study
By IPP Bureau - September 16, 2025
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
GAIASO appoints Dr. Tracey Brown as CEO
By IPP Bureau - September 16, 2025
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Novo Nordisk survey finds Wegovy reduces food noise and improves mental well-being in people with obesity
By IPP Bureau - September 16, 2025
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Brenntag expands partnership with Lallemand to deliver Nutrilife baking enzymes across North America
By IPP Bureau - September 16, 2025
Brenntag will supply Food & Nutrition customers in the United States and Canada with Lallemand’s renowned Nutrilife baking enzyme range
Goa to host historic 10th Ayurveda day on September 23
By IPP Bureau - September 16, 2025
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
Prof. P K Prajapati assumes charge as Director of AIIA, New Delhi
By IPP Bureau - September 16, 2025
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
MoS Health Patel inaugurates National Virus Research & Diagnostic Laboratory Conclave 2025
By IPP Bureau - September 16, 2025
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Advent to sell generic drugmaker Zentiva to GTCR
By IPP Bureau - September 16, 2025
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
HCHB and element5 form strategic alliance to accelerate the agentic AI movement in post-acute care
By IPP Bureau - September 16, 2025
Element5’s Agentic AI platform will be integrated with the HCHB EHR
